ZBIO
ZBIO
NASDAQ · Biotechnology

Zenas Biopharma Inc

$32.17
+0.31 (+0.97%)
As of Aug 8, 1:47 AM ET ·
Financial Highlights (FY 2026)
Revenue
13.79M
Net Income
-520,719,073
Gross Margin
Profit Margin
-3,777.4%
Rev Growth
D/E Ratio
0.32
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 63.1% 63.1% 63.1%
Operating Margin -3,830.6% -0.1% -0.1% -0.1%
Profit Margin -3,777.4% -0.1% -0.1% -0.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 13.79M 140.52M 130.81M 124.82M
Gross Profit 88.66M 82.54M 78.75M
Operating Income -528,140,298 -128,018 -131,088 -117,084
Net Income -520,719,073 -116,113 -126,311 -113,132
Gross Margin 63.1% 63.1% 63.1%
Operating Margin -3,830.6% -0.1% -0.1% -0.1%
Profit Margin -3,777.4% -0.1% -0.1% -0.1%
Rev Growth -3.7% +16.0% -9.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 243.11M 299.15M 339.29M 361.86M
Total Equity 748.72M 337.93M 370.10M 341.01M
D/E Ratio 0.32 0.89 0.92 1.06
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -527,976,632 -178,287 -168,053 -162,378
Free Cash Flow -139,366 -118,293 -114,579